Zulekha Hospital Dubai offers advanced Rhabdomyosarcoma (RMS) Treatment using modern pediatric oncology techniques and internationally accepted treatment protocols. Established in 2004, the JCI hospital is located in Dubai, United Arab Emirates and has 179 beds, providing comprehensive cancer care for local and international patients.

Rhabdomyosarcoma (RMS) Treatment depends on factors such as the tumor's location, size, stage, histological characteristics, and whether it has spread to other parts of the body. Treatment commonly involves a combination of chemotherapy, surgery, and radiation therapy, depending on the individual case. Before treatment, doctors typically perform a biopsy, imaging studies, and staging investigations to determine the extent of disease. Regular monitoring and supportive care help manage treatment effects and assess the response to therapy.